Detalhe da pesquisa
1.
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial.
Lancet Oncol
; 24(10): 1109-1118, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37708912
2.
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial.
Int J Cancer
; 151(8): 1394-1404, 2022 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35583992
3.
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
N Engl J Med
; 378(3): 230-240, 2018 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29342393
4.
Central radiology assessment of the randomized phase III open-label OVHIPEC-1 trial in ovarian cancer.
Int J Gynecol Cancer
; 30(12): 1928-1934, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33046576
5.
Identification of first-stage labor arrest by electromyography in term nulliparous women after induction of labor.
Acta Obstet Gynecol Scand
; 96(7): 868-876, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28295156
6.
Translational and pharmacological principles of hyperthermic intraperitoneal chemotherapy for ovarian cancer.
Best Pract Res Clin Obstet Gynaecol
; 78: 86-102, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34565676
7.
Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial.
J Clin Oncol
; 37(23): 2041-2050, 2019 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31251694
8.
Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence.
Maturitas
; 60(2): 138-47, 2008 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18547757
9.
Trends in maternal mortality: a 13-year hospital-based study in rural Ghana.
Eur J Obstet Gynecol Reprod Biol
; 107(2): 135-9, 2003 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-12648857
10.
Unexpected placebo response in premenstrual dysphoric disorder: implication of endogenous opioids.
Psychopharmacology (Berl)
; 182(2): 318-9, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16001107